Covid-19 jabs for healthy children aged between 12 and 15 are not being recommended by the Government’s vaccine advisers. The Joint Committee on Vaccination and Immunisation (JCVI) has announced that ...

Shares of Moderna MRNA were up 4% yesterday after the company announced positive preliminary immunogenicity data from an ongoing phase IV study, which evaluated the updated version of its COVID-19 ...

The FDA, on Aug 22, approved/authorized the updated mRNA-based COVID-19 vaccines of Pfizer PFE/BioNTech BNTX and Moderna MRNA that target the KP.2 strain of the virus. While the agency approved Pfizer ...

Booster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the ...

Coronavirus is never too far from public consciousness even though it has been five and a half years since lockdown. There are concerns about new variants spreading within the community, making ...

Co-administration of COVID-19 and influenza vaccines did not have a significant impact on any immunogenicity, with geometric mean ratios exceeding 0.67 for enzyme-linked immunosorbent assay (ELISA), ...